TCEAL9 and acute myeloid leukemia: In this study, we have developed an unbiased bioinformatic pipeline to screen five independent patient gene expression arrays through which we show that higher expression of WBP5 can serve to predict inferior outcome in patients with AML, thus providing a new potential stratification for therapy choices.